Methods

The Department of Neurodegeneration uses modern molecular imaging methods, including positron emission tomography (PET) to detect protein pathologies in the brain, such as amyloid plaques or tau aggregates, as well as methods to assess the adenosine transmitter system, synaptic density and cerebral glucose metabolism. Modern magnetic resonance imaging (MRI) procedures such as structural MRI (including high-field MRI using 7 Tesla), functional MRI/activation studies and studies on functional connectivity are also part of the method portfolio. PET/CT, MRI and hybrid PET/MRI devices are used. Finally, the department also applies modern data science methods such as artificial intelligence/deep learning for image data analysis.

Positron emission tomography (PET)

Magnetic resonance imaging (MRI)

Electroencephalography (EEG)

Last Modified: 25.09.2024